{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:29:17Z","timestamp":1760711357905,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["1400-3-99-56423","1400-3-99-56423","1400-3-99-56423","1400-3-99-56423","1400-3-99-56423","1400-3-99-56423"],"award-info":[{"award-number":["1400-3-99-56423","1400-3-99-56423","1400-3-99-56423","1400-3-99-56423","1400-3-99-56423","1400-3-99-56423"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Human T-cell Lymphotropic virus type 1 (HTLV-1) belongs to <jats:italic>retroviridae<\/jats:italic> which is connected to two major diseases, including HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) and Adult T-cell leukemia\/lymphoma (ATLL). This study aims to investigate the mRNA expressions of key proteins correlated to T-cell activation in asymptomatic carriers (ACs) HTLV-1 infected patients, shedding light on early molecular events and T-cell activation following HTLV-1 infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and Methods<\/jats:title>\n                <jats:p>The study involved 40 participants, including 20 ACs and 20 healthy subjects. Blood samples were collected, ELISA assessment for screening and confirmation with PCR for Trans-activating transcriptional regulatory protein (Tax) and HTLV-1 basic leucine zipper factor (HBZ) of the HTLV-1 were done. mRNA expressions of C-terminal Src kinase (CSK), Glycogen Synthase Kinase-3 Beta (GSK3\u03b2), Mitogen-Activated Protein Kinase 14 (MAP3K14 or NIK), Phospholipase C Gamma-1 (PLCG1), Protein Tyrosine Phosphatase non-Receptor Type 6 (PTPN6) and Mitogen-Activated Protein Kinase Kinase Kinase-7 (SLP-76) and Mitogen-Activated Protein Kinase14 (MAP3K7 or TAK1) were assayed using RT-qPCR. Statistical analyses were performed using PRISM and SPSS software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>While there were no significant upregulation in CSK and PTPN6 in ACs compared to healthy individuals, expression levels of GSK3\u03b2, MAP3K14, PLCG1, SLP-76, and TAK1 were significantly higher in ACs compared to healthy subjects which directly contributes to T-cell activation in the HTLV-1 ACs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>HTLV-1 infection induces differential mRNA expressions in key proteins associated with T-cell activation. mRNAs related to T-cell activation showed significant upregulation compared to PTPN6 and CSK which contributed to T-cell regulation. Understanding these early molecular events in ACs may provide potential markers for disease progression and identify therapeutic targets for controlling viral replication and mitigating associated diseases. The study contributes novel insights to the limited literature on T-cell activation and HTLV-1 pathogenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13027-024-00584-5","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T08:01:38Z","timestamp":1715414498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation"],"prefix":"10.1186","volume":"19","author":[{"given":"Arash","family":"Letafati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Bahavar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alijan","family":"Tabarraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdollah","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed-Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"584_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CR Bangham","year":"2018","unstructured":"Bangham CR. Human T cell leukemia virus type 1: persistence and pathogenesis. Annu Rev Immunol. 2018;36:43\u201371.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"584_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-023-02177-5","volume":"40","author":"A Letafati","year":"2023","unstructured":"Letafati A, Mozhgani S-H, Marjani A, Amiri A, Siami Z, Mohammaditabar M, et al. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals. Med Oncol. 2023;40(11):1\u201311.","journal-title":"Med Oncol"},{"issue":"11","key":"584_CR3","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1586\/1744666X.2014.966690","volume":"10","author":"F Martin","year":"2014","unstructured":"Martin F, Taylor GP, Jacobson S. Inflammatory manifestations of HTLV-1 and their therapeutic options. Expert Rev Clin Immunol. 2014;10(11):1531\u201346.","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"584_CR4","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/tmi.13305","volume":"24","author":"AM Ngoma","year":"2019","unstructured":"Ngoma AM, Omokoko MD, Mutombo PB, Mvika ES, Muwonga JM, Nollet KE, Ohto H. Population-based prevalence of human T-lymphotropic virus type 1 in sub-Saharan Africa: a systematic review and meta-analysis. Tropical Med Int Health. 2019;24(11):1277\u201390.","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"584_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-017-0484-y","volume":"18","author":"RF Santos","year":"2017","unstructured":"Santos RF, Concei\u00e7\u00e3o GC, Martins MS, Kraychete A, Penalva MA, Carvalho EM, et al. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients. BMC Nephrol. 2017;18(1):1\u20137.","journal-title":"BMC Nephrol"},{"issue":"3","key":"584_CR6","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2741\/2022","volume":"11","author":"K Tasken","year":"2006","unstructured":"Tasken K, Ruppelt A. Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts. Front Biosci-Landmark. 2006;11(3):2929\u201339.","journal-title":"Front Biosci-Landmark"},{"issue":"4","key":"584_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1084\/jem.193.4.497","volume":"193","author":"T Vang","year":"2001","unstructured":"Vang T, Torgersen KM, Sundvold V, Saxena M, Levy FO, Sk\u00e5lhegg BS, et al. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med. 2001;193(4):497\u2013508.","journal-title":"J Exp Med"},{"issue":"6","key":"584_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nri1632","volume":"5","author":"F Macian","year":"2005","unstructured":"Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005;5(6):472\u201384.","journal-title":"Nat Rev Immunol"},{"key":"584_CR9","doi-asserted-by":"crossref","unstructured":"Liu W-H, Yubing F, Wang J, Liu C, Liao K, Gao X, et al. Glycogen synthase kinase 3 controls T cell exhaustion by regulating NFAT activation. 2023.","DOI":"10.21203\/rs.3.rs-2678038\/v1"},{"issue":"6","key":"584_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/biom13060915","volume":"13","author":"K Kanemaru","year":"2023","unstructured":"Kanemaru K, Nakamura Y. Activation mechanisms and diverse functions of mammalian phospholipase C. Biomolecules. 2023;13(6):915.","journal-title":"Biomolecules"},{"issue":"19","key":"584_CR11","doi-asserted-by":"publisher","first-page":"13026","DOI":"10.1074\/jbc.M113.547018","volume":"289","author":"W Liu","year":"2014","unstructured":"Liu W, Cai M-J, Zheng C-C, Wang J-X, Zhao X-F. Phospholipase C\u03b31 connects the cell membrane pathway to the nuclear receptor pathway in insect steroid hormone signaling. J Biol Chem. 2014;289(19):13026\u201341.","journal-title":"J Biol Chem"},{"issue":"1","key":"584_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/bj20021637","volume":"371","author":"T Mustelin","year":"2003","unstructured":"Mustelin T, Task\u00e9n K. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochemical Journal. 2003;371(1):15\u201327.","journal-title":"Biochemical Journal"},{"key":"584_CR13","doi-asserted-by":"crossref","unstructured":"Zhang J, Somani A-K, Siminovitch KA, editors. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Seminars in immunology; 2000: Elsevier.","DOI":"10.1006\/smim.2000.0223"},{"issue":"8","key":"584_CR14","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M","volume":"29","author":"J Brockdorff","year":"1999","unstructured":"Brockdorff J, Williams S, Couture C, Mustelin T. Dephosphorylation of ZAP-70 and inhibition of T cell activation by activated SHP1. Eur J Immunol. 1999;29(8):2539\u201350.","journal-title":"Eur J Immunol"},{"issue":"8","key":"584_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ni1355","volume":"7","author":"YY Wan","year":"2006","unstructured":"Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol. 2006;7(8):851\u20138.","journal-title":"Nat Immunol"},{"issue":"31","key":"584_CR16","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.1073\/pnas.0603089103","volume":"103","author":"H-H Liu","year":"2006","unstructured":"Liu H-H, Xie M, Schneider MD, Chen ZJ. Essential role of TAK1 in thymocyte development and activation. Proc Natl Acad Sci. 2006;103(31):11677\u201382.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"584_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/iub.1078","volume":"64","author":"L Dai","year":"2012","unstructured":"Dai L, Aye Thu C, Liu XY, Xi J, Cheung PC. TAK1, more than just innate immunity. IUBMB Life. 2012;64(10):825\u201334.","journal-title":"IUBMB Life"},{"issue":"10","key":"584_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12032-023-02166-8","volume":"40","author":"A Letafati","year":"2023","unstructured":"Letafati A, Soheili R, Norouzi M, Soleimani P, Mozhgani S-H. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia\/lymphoma: a comprehensive review. Med Oncol. 2023;40(10):295.","journal-title":"Med Oncol"},{"key":"584_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.12688\/f1000research.17479.1","volume":"8","author":"Y Tagaya","year":"2019","unstructured":"Tagaya Y, Matsuoka M, Gallo R. 40 years of the human T-cell leukemia virus: past, present, and future. F1000Research. 2019;8:228.","journal-title":"F1000Research."},{"issue":"4","key":"584_CR20","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2741\/2163","volume":"12","author":"C-Z Giam","year":"2007","unstructured":"Giam C-Z, Jeang K-T. HTLV-1 Tax and adult T-cell leukemia. Front Biosci-Landmark. 2007;12(4):1496\u2013507.","journal-title":"Front Biosci-Landmark"},{"issue":"4","key":"584_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/jcb.240460405","volume":"46","author":"CL Tendler","year":"1991","unstructured":"Tendler CL, Greenberg SJ, Burton JD, Danielpour D, Kim SJ, Blattner WA, et al. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem. 1991;46(4):302\u201311.","journal-title":"J Cell Biochem"},{"issue":"25","key":"584_CR22","doi-asserted-by":"publisher","first-page":"14559","DOI":"10.1073\/pnas.251540598","volume":"98","author":"N Azimi","year":"2001","unstructured":"Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM\/TSP patients. Proc Natl Acad Sci. 2001;98(25):14559\u201364.","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"584_CR23","first-page":"1071","volume":"129","author":"T Watanabe","year":"2017","unstructured":"Watanabe T. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1\u2013infected T cells Blood. J Am Soc Hematol. 2017;129(9):1071\u201381.","journal-title":"J Am Soc Hematol"},{"key":"584_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fmicb.2012.00334","volume":"3","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi M, Watanabe T. Molecular hallmarks of adult T cell leukemia. Front Microbiol. 2012;3:334.","journal-title":"Front Microbiol"},{"key":"584_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s13238-012-2047-0","volume":"3","author":"H Cheng","year":"2012","unstructured":"Cheng H, Ren T, Sun S-C. New insight into the oncogenic mechanism of the retroviral oncoprotein Tax. Protein cell. 2012;3:581\u20139.","journal-title":"Protein cell"},{"key":"584_CR26","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.2741\/1417","volume":"9","author":"B Michael","year":"2004","unstructured":"Michael B, Nair A, Lairmore MD. Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front Biosci. 2004;9:2556.","journal-title":"Front Biosci"},{"issue":"1","key":"584_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbapap.2007.08.012","volume":"1784","author":"E Ingley","year":"2008","unstructured":"Ingley E. Src family kinases: regulation of their activities, levels and identification of new pathways. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics. 2008;1784(1):56\u201365.","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"3","key":"584_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/08977190500178877","volume":"23","author":"Y-P Chong","year":"2005","unstructured":"Chong Y-P, Mulhern TD, Cheng H-C. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)\u2014endogenous negative regulators of Src-family protein kinases: Mini Review. Growth Factors. 2005;23(3):233\u201344.","journal-title":"Growth Factors"},{"issue":"48","key":"584_CR29","first-page":"7990","volume":"23","author":"EH Palacios","year":"2004","unstructured":"Palacios EH, Weiss A. Function of the Src-family kinases, Lck and Fyn. T-cell Dev Act Oncogene. 2004;23(48):7990\u20138000.","journal-title":"T-cell Dev Act Oncogene"},{"key":"584_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.608747","volume":"8","author":"P Castro-Sanchez","year":"2020","unstructured":"Castro-Sanchez P, Teagle AR, Prade S, Zamoyska R. Modulation of TCR signaling by tyrosine phosphatases: from autoimmunity to immunotherapy. Front Dev Biol. 2020;8: 608747.","journal-title":"Front Dev Biol"},{"issue":"1","key":"584_CR31","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1038\/s41467-022-34724-5","volume":"13","author":"D Sridaran","year":"2022","unstructured":"Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S, et al. Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance. Nat Commun. 2022;13(1):6929.","journal-title":"Nat Commun"},{"issue":"1","key":"584_CR32","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1038\/s41598-017-02280-4","volume":"7","author":"AM Wallis","year":"2017","unstructured":"Wallis AM, Wallace EC, Hostager BS, Yi Z, Houtman JC, Bishop GA. TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22. Sci Rep. 2017;7(1):2081.","journal-title":"Sci Rep"},{"issue":"8","key":"584_CR33","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1074\/jbc.RA119.011150","volume":"295","author":"J-E Park","year":"2020","unstructured":"Park J-E, Brand DD, Rosloniec EF, Yi A-K, Stuart JM, Kang AH, Myers LK. Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway. J Biol Chem. 2020;295(8):2239\u201347.","journal-title":"J Biol Chem"},{"key":"584_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.canlet.2018.06.035","volume":"433","author":"S Sengupta","year":"2018","unstructured":"Sengupta S, Katz SC, Sengupta S, Sampath P. Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells. Cancer Lett. 2018;433:131\u20139.","journal-title":"Cancer Lett"},{"key":"584_CR35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3389\/fonc.2020.01221","volume":"10","author":"A Dimou","year":"2020","unstructured":"Dimou A, Syrigos KN. The role of GSK3\u03b2 in T lymphocytes in the tumor microenvironment. Front Oncol. 2020;10:1221.","journal-title":"Front Oncol"},{"issue":"1","key":"584_CR36","doi-asserted-by":"publisher","first-page":"12632","DOI":"10.1038\/ncomms12632","volume":"7","author":"C-W Li","year":"2016","unstructured":"Li C-W, Lim S-O, Xia W, Lee H-H, Chan L-C, Kuo C-W, et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun. 2016;7(1):12632.","journal-title":"Nat Commun"},{"issue":"1","key":"584_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/15384047.2022.2088984","volume":"23","author":"A Hsu","year":"2022","unstructured":"Hsu A, Huntington KE, De Souza A, Zhou L, Olszewski AJ, Makwana NP, et al. Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3\u03b2) inhibitor, in refractory adult T-Cell leukemia\/lymphoma. Cancer Biol Ther. 2022;23(1):417\u201323.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"584_CR38","doi-asserted-by":"publisher","first-page":"166601","DOI":"10.1016\/j.bbadis.2022.166601","volume":"1869","author":"C Prawiro","year":"2023","unstructured":"Prawiro C, Bunney TD, Kampyli C, Yaguchi H, Katan M, Bangham CR. A frequent PLC\u03b31 mutation in adult T-cell leukemia\/lymphoma determines functional properties of the malignant cells. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2023;1869(2):166601.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease."},{"issue":"9","key":"584_CR39","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/cas.13303","volume":"108","author":"Y Kogure","year":"2017","unstructured":"Kogure Y, Kataoka K. Genetic alterations in adult T-cell leukemia\/lymphoma. Cancer Sci. 2017;108(9):1719\u201325.","journal-title":"Cancer Sci"},{"issue":"4","key":"584_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/pathogens9040287","volume":"9","author":"L Prochasson","year":"2020","unstructured":"Prochasson L, Jalinot P, Mocquet V. The complex relationship between HTLV-1 and nonsense-mediated mRNA decay (NMD). Pathogens. 2020;9(4):287.","journal-title":"Pathogens"},{"issue":"11","key":"584_CR41","doi-asserted-by":"publisher","first-page":"e00071","DOI":"10.1128\/MCB.00071-17","volume":"37","author":"J Breuning","year":"2017","unstructured":"Breuning J, Brown MH. T cell costimulation by CD6 is dependent on bivalent binding of a GADS\/SLP-76 complex. Mol Cell Biol. 2017;37(11):e00071-e117.","journal-title":"Mol Cell Biol"},{"issue":"15","key":"584_CR42","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1074\/jbc.M116.759555","volume":"292","author":"YR Thaker","year":"2017","unstructured":"Thaker YR, Recino A, Raab M, Jabeen A, Wallberg M, Fernandez N, Rudd CE. Activated Cdc42-associated kinase 1 (ACK1) binds the sterile \u03b1 motif (SAM) domain of the adaptor SLP-76 and phosphorylates proximal tyrosines. J Biol Chem. 2017;292(15):6281\u201390.","journal-title":"J Biol Chem"},{"issue":"3","key":"584_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41379-021-00937-0","volume":"35","author":"F Vega","year":"2022","unstructured":"Vega F, Amador C, Chadburn A, Hsi ED, Slack G, Medeiros LJ, Feldman AL. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up. Mod Pathol. 2022;35(3):306\u201318.","journal-title":"Mod Pathol"},{"issue":"11","key":"584_CR44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/biology9110390","volume":"9","author":"EW Harhaj","year":"2020","unstructured":"Harhaj EW, Shembade N. Lymphotropic viruses: chronic inflammation and induction of cancers. Biology. 2020;9(11):390.","journal-title":"Biology"},{"key":"584_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drup.2017.10.004","volume":"33","author":"R Santoro","year":"2017","unstructured":"Santoro R, Carbone C, Piro G, Chiao PJ, Melisi D. TAK-ing aim at chemoresistance: the emerging role of MAP3K7 as a target for cancer therapy. Drug Resist Updates. 2017;33:36\u201342.","journal-title":"Drug Resist Updates"},{"issue":"1","key":"584_CR46","first-page":"128","volume":"33","author":"X Chen","year":"2023","unstructured":"Chen X, Zhao H, Kang X, Tai X, Guo W, Shen Y. Liensinine, an isoquinoline-type alkaloid in lotus seeds, suppressed TGF-beta1-Induced proliferation and migration in human tenon capsule fibroblast cells through MAP3K7 gene. Rev Bras. 2023;33(1):128\u201336.","journal-title":"Rev Bras"},{"issue":"12","key":"584_CR47","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/onc.2012.171","volume":"32","author":"C Freudlsperger","year":"2013","unstructured":"Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, et al. TGF-\u03b2 and NF-\u03baB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 2013;32(12):1549\u201359.","journal-title":"Oncogene"},{"issue":"5","key":"584_CR48","doi-asserted-by":"publisher","first-page":"F1471","DOI":"10.1152\/ajprenal.00485.2006","volume":"292","author":"SI Kim","year":"2007","unstructured":"Kim SI, Kwak JH, Zachariah M, He Y, Wang L, Choi ME. TGF-\u03b2-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-\u03b21-induced MKK3-p38 MAPK activation and stimulation of type I collagen. Am J Physiol-Renal Physiol. 2007;292(5):F1471\u20138.","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"33","key":"584_CR49","doi-asserted-by":"publisher","first-page":"22285","DOI":"10.1074\/jbc.M109.007146","volume":"284","author":"SI Kim","year":"2009","unstructured":"Kim SI, Kwak JH, Na H-J, Kim JK, Ding Y, Choi ME. Transforming growth factor-\u03b2 (TGF-\u03b21) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-\u03b2 receptor kinase activity in mesangial cells. J Biol Chem. 2009;284(33):22285\u201396.","journal-title":"J Biol Chem"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-024-00584-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-024-00584-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-024-00584-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T09:14:24Z","timestamp":1715418864000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-024-00584-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/s13027-024-00584-5","relation":{},"ISSN":["1750-9378"],"issn-type":[{"type":"electronic","value":"1750-9378"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Tehran University of Medical Sciences, Tehran, Iran (IR.TUMS.SPH.REC.1400.319).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication of identifiable information\/ images in open access journal was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}